BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18602024)

  • 1. Discovering and improving novel peptide therapeutics.
    McGregor DP
    Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage display-derived peptides as therapeutic alternatives to antibodies.
    Ladner RC; Sato AK; Gorzelany J; de Souza M
    Drug Discov Today; 2004 Jun; 9(12):525-9. PubMed ID: 15183160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to current and future protein therapeutics: a protein engineering perspective.
    Carter PJ
    Exp Cell Res; 2011 May; 317(9):1261-9. PubMed ID: 21371474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein drug stability: a formulation challenge.
    Frokjaer S; Otzen DE
    Nat Rev Drug Discov; 2005 Apr; 4(4):298-306. PubMed ID: 15803194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering antibodies for clinical applications.
    Jain M; Kamal N; Batra SK
    Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum stability of peptides.
    Jenssen H; Aspmo SI
    Methods Mol Biol; 2008; 494():177-86. PubMed ID: 18726574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide drugs to target G protein-coupled receptors.
    Bellmann-Sickert K; Beck-Sickinger AG
    Trends Pharmacol Sci; 2010 Sep; 31(9):434-41. PubMed ID: 20655603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-based biomaterials for protease-enhanced drug delivery.
    Law B; Weissleder R; Tung CH
    Biomacromolecules; 2006 Apr; 7(4):1261-5. PubMed ID: 16602747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PepTalk--CHI's Ninth Annual Meeting--Engineering Protein & Peptide Therapeutics: Peptides.
    Craik D
    IDrugs; 2010 Mar; 13(3):156-8. PubMed ID: 20191429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular engineering and design of therapeutic antibodies.
    Presta LG
    Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More than one reason to rethink the use of peptides in vaccine design.
    Purcell AW; McCluskey J; Rossjohn J
    Nat Rev Drug Discov; 2007 May; 6(5):404-14. PubMed ID: 17473845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grafting of material-binding function into antibodies Functionalization by peptide grafting.
    Hattori T; Umetsu M; Nakanishi T; Tsumoto K; Ohara S; Abe H; Naito M; Asano R; Adschiri T; Kumagai I
    Biochem Biophys Res Commun; 2008 Jan; 365(4):751-7. PubMed ID: 18039464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and application of stimulus-responsive peptide systems.
    Chockalingam K; Blenner M; Banta S
    Protein Eng Des Sel; 2007 Apr; 20(4):155-61. PubMed ID: 17376876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids.
    Gregoriadis G; Jain S; Papaioannou I; Laing P
    Int J Pharm; 2005 Aug; 300(1-2):125-30. PubMed ID: 16046256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional peptides by genome reverse engineering.
    Grigorov MG; van Bladeren PJ
    Curr Opin Drug Discov Devel; 2007 May; 10(3):341-6. PubMed ID: 17554861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid profiling of peptide stability in proteolytic environments.
    Gorris HH; Bade S; Röckendorf N; Albers E; Schmidt MA; Fránek M; Frey A
    Anal Chem; 2009 Feb; 81(4):1580-6. PubMed ID: 19159331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.